Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation
Expert Rev Cardiovasc Ther. 2024 Mar 13. doi: 10.1080/14779072.2024.2330657. Online ahead of print.ABSTRACTINTRODUCTION: The Fontan procedure is the palliative procedure of choice for patients with single ventricle physiology. Pulmonary vascular disease (PVD) is an important contributor to Fontan circulatory failure.AREAS COVERED: We review the pathophysiology of PVD in patients with Fontan palliation and share our initial experience with optical coherence tomography (OCT) in supplementing standard hemodynamics in characterizing Fontan-associated PVD. In the absence of a sub-pulmonary ventricle, low pulmonary vascular resi...
Source: Expert Review of Cardiovascular Therapy - March 13, 2024 Category: Cardiology Authors: Marie-A Chaix R éda Ibrahim Jean-Claude Tardif Colombe Roy Fran çois-Pierre Mongeon Annie Dore Blandine Mond ésert Paul Khairy Source Type: research

Why selective screening for asymptomatic carotid stenosis is Currently appropriate: a special report
This article presents the rationale for such a program.AREAS COVERED: The benefits of selective screening for AsxCS include early recognition of AsxCS allowing timely initiation of preventive measures to reduce future myocardial infarction (MI), stroke, cardiac death and cardiovascular (CV) event rates.EXPERT OPINION: Mass screening programs for AsxCS are neither clinically effective nor cost-effective. Nevertheless, targeted screening of populations at high risk for AsxCS provides an opportunity to identify these individuals earlier rather than later and to initiate a number of lifestyle measures, risk factor modification...
Source: Expert Review of Cardiovascular Therapy - March 13, 2024 Category: Cardiology Authors: Kosmas I Paraskevas Alan Dardik Marc L Schermerhorn Christos D Liapis Armando Mansilha Brajesh K Lal William A Gray Martin M Brown Piotr Myrcha Carl J Lavie Clark J Zeebregts Eric A Secemsky Luca Saba Matthew Blecha Victor Gurevich Mauro Silvestrini Ales Source Type: research

Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database
CONCLUSION: Despite generally being older and having more comorbidities, women with FH fair equally with men with FH in terms of mortality during AMI admission.PMID:38459907 | DOI:10.1080/14779072.2024.2329720 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - March 9, 2024 Category: Cardiology Authors: Frederick Berro Rivera Sung Whoy Cha Mara Bernadette Liston Sonny Redula Nathan Ross B Bantayan Nishant Shah Mamas A Mamas Annabelle Santos Volgman Source Type: research

Sex differences in trends and In-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database
CONCLUSION: Despite generally being older and having more comorbidities, women with FH fair equally with men with FH in terms of mortality during AMI admission.PMID:38459907 | DOI:10.1080/14779072.2024.2329720 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - March 9, 2024 Category: Cardiology Authors: Frederick Berro Rivera Sung Whoy Cha Mara Bernadette Liston Sonny Redula Nathan Ross B Bantayan Nishant Shah Mamas A Mamas Annabelle Santos Volgman Source Type: research

Should patients with diabetes be routinely screened for atrial fibrillation?
Expert Rev Cardiovasc Ther. 2024 Mar 7. doi: 10.1080/14779072.2024.2328645. Online ahead of print.NO ABSTRACTPMID:38453648 | DOI:10.1080/14779072.2024.2328645 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - March 7, 2024 Category: Cardiology Authors: Prashant D Bhave Elsayed Soliman Source Type: research

When to ablate in Brugada and early repolarization syndromes
Expert Rev Cardiovasc Ther. 2024 Mar 7:1-8. doi: 10.1080/14779072.2024.2326549. Online ahead of print.ABSTRACTINTRODUCTION: Mapping advances have expanded both the feasibility and benefits of ablation as a therapeutic approach, including in the treatment of two heart conditions that contribute to sudden cardiac death in young people: Brugada syndrome (BrS) and early repolarization syndrome (ERS). Although these conditions share a number of similarities, debates persist regarding the underlying pathophysiology and origin of the ventricular arrhythmias associated with them.AREAS COVERED: By synthesizing available data (PubMe...
Source: Expert Review of Cardiovascular Therapy - March 1, 2024 Category: Cardiology Authors: Eloi Vacher Jean Baptiste Gourraud Vincent Probst Source Type: research

When to ablate in Brugada and early repolarization syndromes
Expert Rev Cardiovasc Ther. 2024 Mar 1. doi: 10.1080/14779072.2024.2326549. Online ahead of print.ABSTRACTINTRODUCTION: Mapping advances have expanded both the feasibility and benefits of ablation as a therapeutic approach, including in the treatment of two heart conditions that contribute to sudden cardiac death in young people: Brugada syndrome (BrS) and early repolarization syndrome (ERS). Although these conditions share a number of similarities, debates persist regarding the underlying pathophysiology and origin of the ventricular arrhythmias associated with them.AREAS COVERED: By synthesizing available data (PubMed), ...
Source: Expert Review of Cardiovascular Therapy - March 1, 2024 Category: Cardiology Authors: Eloi Vacher Jean Baptiste Gourraud Vincent Probst Source Type: research

A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
CONCLUSIONS: Empagliflozin is the first treatment with established efficacy and cost-effectiveness for HF patients across EF from the perspective of healthcare payers in Spain. Empagliflozin also proved to be cost-effective for all subgroups of patients included in the analysis.PMID:38416135 | DOI:10.1080/14779072.2024.2324027 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - February 28, 2024 Category: Cardiology Authors: Xavier Garc ía-Moll Francesco Croci Alexandra Sol é Elisabeth S Hartgers-Gubbels Miguel A Calleja-Hern ández Source Type: research